MedPath
NMPA Approval

Palonosetron Hydrochloride Injection

国药准字HJ20250053

April 30, 2025

Drug Information

盐酸帕洛诺司琼注射液

注射剂

5ml:0.25mg(按C₁₉H₂₄N₂O 计)

化学药品

April 30, 2025

April 29, 2030

Company Information

Applicant Company

RAFARM S.A.

Korinthou 12, Neo Psihiko, 154 51, Greece

Manufacturing Company

RAFARM S.A.

Thesi Pousi Xatzi, Agiou Louka, Paiania, 190 02, Greece

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸帕洛诺司琼注射液 - NMPA 批准文号 | MedPath